Published Application/Species/Sample/Dilution | Reference |
---|
- flow cytometry; SARS coronavirus
- neutralization; SARS coronavirus
- ELISA; SARS coronavirus
| Bondareva M, Budzinski L, Durek P, Witkowski M, Angermair S, Ninnemann J, et al. Cross-regulation of antibody responses against the SARS-CoV-2 Spike protein and commensal microbiota via molecular mimicry. Cell Host Microbe. 2023;31:1866-1881.e10 pubmed publisher
|
- flow cytometry; SARS coronavirus
- neutralization; SARS coronavirus
- ELISA; SARS coronavirus
| Deo S, Desai K, Patare A, Wadapurkar R, Rade S, Mahudkar S, et al. Evaluation of self-amplifying mRNA platform for protein expression and genetic stability: Implication for mRNA therapies. Biochem Biophys Res Commun. 2023;680:108-118 pubmed publisher
|
- flow cytometry; SARS coronavirus
- neutralization; SARS coronavirus
- ELISA; SARS coronavirus
| Vanhulle E, Doijen J, Stroobants J, Provinciael B, Noppen S, Schols D, et al. Cellular electrical impedance to profile SARS-CoV-2 fusion inhibitors and to assess the fusogenic potential of spike mutants. Antiviral Res. 2023;213:105587 pubmed publisher
|
- flow cytometry; SARS coronavirus
- neutralization; SARS coronavirus
- ELISA; SARS coronavirus
| Miao L, Yan C, Chen Y, Zhou W, Zhou X, Qiao Q, et al. SIM imaging resolves endocytosis of SARS-CoV-2 spike RBD in living cells. Cell Chem Biol. 2023;30:248-260.e4 pubmed publisher
|
- flow cytometry; SARS coronavirus
- neutralization; SARS coronavirus
- ELISA; SARS coronavirus
| Imanishi I, Asahina R, Hayashi S, Uchiyama J, Hisasue M, Yamasaki M, et al. Guest edited collection serological study of SARS-CoV-2 antibodies in japanese cats using protein-A/G-based ELISA. BMC Vet Res. 2022;18:443 pubmed publisher
|
- flow cytometry; SARS coronavirus
- neutralization; SARS coronavirus
- ELISA; SARS coronavirus
| Gourdelier M, Swain J, Arone C, Mouttou A, Bracquemond D, Merida P, et al. Optimized production and fluorescent labeling of SARS-CoV-2 virus-like particles. Sci Rep. 2022;12:14651 pubmed publisher
|
- flow cytometry; SARS coronavirus
- neutralization; SARS coronavirus
- ELISA; SARS coronavirus
| Prout A, Rustandi R, Tubbs C, Winters M, McKenna P, Vlasak J. Functional profiling of Covid 19 vaccine candidate by flow virometry. Vaccine. 2022;40:5529-5536 pubmed publisher
|
- flow cytometry; SARS coronavirus
- neutralization; SARS coronavirus
- ELISA; SARS coronavirus
| Tsukinoki K, Yamamoto T, Saito J, Sakaguchi W, Iguchi K, Inoue Y, et al. Prevalence of saliva immunoglobulin A antibodies reactive with severe acute respiratory syndrome coronavirus 2 among Japanese people unexposed to the virus. Microbiol Immunol. 2022;66:403-410 pubmed publisher
|
- flow cytometry; SARS coronavirus
- neutralization; SARS coronavirus
- ELISA; SARS coronavirus
| Wu W, Tan X, Zupancic J, Schardt J, Desai A, Smith M, et al. Rapid and Quantitative In Vitro Evaluation of SARS-CoV-2 Neutralizing Antibodies and Nanobodies. Anal Chem. 2022;94:4504-4512 pubmed publisher
|
- flow cytometry; domestic rabbit
- neutralization; domestic rabbit
- ELISA; domestic rabbit
- flow cytometry; SARS coronavirus
- neutralization; SARS coronavirus
- ELISA; SARS coronavirus
| Liu F, Feng C, Xu S, Wu Q, Tang J, Chen Y, et al. An AAV vaccine targeting the RBD of the SARS-CoV-2 S protein induces effective neutralizing antibody titers in mice and canines. Vaccine. 2022;40:1208-1212 pubmed publisher
|
- flow cytometry; SARS coronavirus
- neutralization; SARS coronavirus
- ELISA; SARS coronavirus
| Nguyen L, Yang D, Nicolaescu V, Best T, Gula H, Saxena D, et al. Cannabidiol inhibits SARS-CoV-2 replication through induction of the host ER stress and innate immune responses. Sci Adv. 2022;8:eabi6110 pubmed publisher
|
- flow cytometry; SARS coronavirus
- neutralization; SARS coronavirus
- ELISA; SARS coronavirus
| Du S, Xu W, Wang Y, Li L, Hao P, Tian M, et al. The "LLQY" Motif on SARS-CoV-2 Spike Protein Affects S Incorporation into Virus Particles. J Virol. 2022;96:e0189721 pubmed publisher
|
- flow cytometry; SARS coronavirus
- neutralization; SARS coronavirus
- ELISA; SARS coronavirus
- flow cytometry; domestic rabbit
- neutralization; domestic rabbit
- ELISA; domestic rabbit
| Vanderheijden N, Stevaert A, Xie J, Ren X, Barbezange C, Noppen S, et al. Functional Analysis of Human and Feline Coronavirus Cross-Reactive Antibodies Directed Against the SARS-CoV-2 Fusion Peptide. Front Immunol. 2021;12:790415 pubmed publisher
|
- flow cytometry; SARS coronavirus
- neutralization; SARS coronavirus
- ELISA; SARS coronavirus
- flow cytometry; domestic rabbit
- neutralization; domestic rabbit
- ELISA; domestic rabbit
| Tsukinoki K, Yamamoto T, Handa K, Iwamiya M, Saruta J, Ino S, et al. Detection of cross-reactive immunoglobulin A against the severe acute respiratory syndrome-coronavirus-2 spike 1 subunit in saliva. PLoS ONE. 2021;16:e0249979 pubmed publisher
|
- flow cytometry; SARS coronavirus
- neutralization; SARS coronavirus
- ELISA; SARS coronavirus
- flow cytometry; domestic rabbit
- neutralization; domestic rabbit
- ELISA; domestic rabbit
| Rauch S, Roth N, Schwendt K, Fotin Mleczek M, Mueller S, Petsch B. mRNA-based SARS-CoV-2 vaccine candidate CVnCoV induces high levels of virus-neutralising antibodies and mediates protection in rodents. NPJ Vaccines. 2021;6:57 pubmed publisher
|
- flow cytometry; SARS coronavirus
- neutralization; SARS coronavirus
- ELISA; SARS coronavirus
- flow cytometry; domestic rabbit
- neutralization; domestic rabbit
- ELISA; domestic rabbit
| de Vries M, Mohamed A, Prescott R, Valero Jimenez A, Desvignes L, O Connor R, et al. A comparative analysis of SARS-CoV-2 antivirals characterizes 3CLpro inhibitor PF-00835231 as a potential new treatment for COVID-19. J Virol. 2021;: pubmed publisher
|
- flow cytometry; domestic rabbit
- neutralization; domestic rabbit
- ELISA; domestic rabbit
- flow cytometry; SARS coronavirus
- neutralization; SARS coronavirus
- ELISA; SARS coronavirus
| Theuerkauf S, Michels A, Riechert V, Maier T, Flory E, Cichutek K, et al. Quantitative assays reveal cell fusion at minimal levels of SARS-CoV-2 spike protein and fusion from without. iScience. 2021;24:102170 pubmed publisher
|
- flow cytometry; domestic rabbit
- neutralization; domestic rabbit
- ELISA; domestic rabbit
- flow cytometry; SARS coronavirus
- neutralization; SARS coronavirus
- ELISA; SARS coronavirus
| Baisa G, Rancour D, Mansfield K, Burns M, MARTIN L, Cunha D, et al. A Recombinant Protein SARS-CoV-2 Candidate Vaccine Elicits High-titer Neutralizing Antibodies in Macaques. Res Sq. 2021;: pubmed publisher
|
- flow cytometry; domestic rabbit
- neutralization; domestic rabbit
- ELISA; domestic rabbit
- flow cytometry; SARS coronavirus
- neutralization; SARS coronavirus
- ELISA; SARS coronavirus
| Baisa G, Rancour D, Mansfield K, Burns M, MARTIN L, Cunha D, et al. A recombinant protein SARS-CoV-2 candidate vaccine elicits high-titer neutralizing antibodies in macaques. bioRxiv. 2020;: pubmed publisher
|
- flow cytometry; SARS coronavirus
- neutralization; SARS coronavirus
- ELISA; SARS coronavirus
- flow cytometry; domestic rabbit
- neutralization; domestic rabbit
- ELISA; domestic rabbit
| Havranek K, Jimenez A, Acciani M, Lay Mendoza M, Reyes Ballista J, Diaz D, et al. SARS-CoV-2 Spike Alterations Enhance Pseudoparticle Titers and Replication-Competent VSV-SARS-CoV-2 Virus. Viruses. 2020;12: pubmed publisher
|
- flow cytometry; SARS coronavirus
- neutralization; SARS coronavirus
- ELISA; SARS coronavirus
- flow cytometry; domestic rabbit
- neutralization; domestic rabbit
- ELISA; domestic rabbit
| de Vries M, Mohamed A, Prescott R, Valero Jimenez A, Desvignes L, O Connor R, et al. A comparative analysis of SARS-CoV-2 antivirals in human airway models characterizes 3CLpro inhibitor PF-00835231 as a potential new treatment for COVID-19. bioRxiv. 2021;: pubmed publisher
|
| Yang J, Wang J, Zhang H, Li S, Wang X, Baimanov D, et al. Rapid Detection of Spike Protein Receptor Binding Region of SARS-CoV-2 and Its Variants Using a Nanosheet Probe. Anal Chem. 2025;97:3729-3738 pubmed publisher
|
| Hunt A, V xf6 geli B, Hassan A, Guerrero L, Kightlinger W, Yoesep D, et al. A rapid cell-free expression and screening platform for antibody discovery. Nat Commun. 2023;14:3897 pubmed publisher
|
| Vanhulle E, Stroobants J, Provinciael B, Camps A, Noppen S, Maes P, et al. SARS-CoV-2 Permissive glioblastoma cell line for high throughput antiviral screening. Antiviral Res. 2022;203:105342 pubmed publisher
|
| Troyer Z, Alhusaini N, Tabler C, Sweet T, de Carvalho K, Schlatzer D, et al. Extracellular vesicles carry SARS-CoV-2 spike protein and serve as decoys for neutralizing antibodies. J Extracell Vesicles. 2021;10:e12112 pubmed publisher
|